Myeloid-Derived Suppressor Cells Are a Major Source of Wnt5A in the Melanoma Microenvironment and Depend on Wnt5A for Full Suppressive Activity
- 1 February 2021
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 81 (3), 658-670
- https://doi.org/10.1158/0008-5472.can-20-1238
Abstract
Metastatic dissemination remains a significant barrier to successful therapy for melanoma. Wnt5A is a potent driver of invasion in melanoma and is believed to be secreted from the tumor microenvironment (TME). Our data suggest that myeloid-derived suppressor cells (MDSC) in the TME are a major source of Wnt5A and are reliant upon Wnt5A for multiple actions. Knockdown of Wnt5A specifically in the myeloid cells demonstrated a clear decrease in Wnt5A expression within the TME in vivo as well as a decrease in intratumoral MDSC and regulatory T cell (Treg). Wnt5A knockdown also decreased the immunosuppressive nature of MDSC and decreased expression of TGFβ1 and arginase 1. In the presence of Wnt5A-depleted MDSC, tumor-infiltrating lymphocytes expressed decreased PD-1 and LAG3, suggesting a less exhausted phenotype. Myeloid-specific Wnt5A knockdown also led to decreased lung metastasis. Tumor-infiltrating MDSC from control animals showed a strong positive correlation with Treg, which was completely ablated in animals with Wnt5A-negative MDSC. Overall, our data suggest that while MDSC contribute to an immunosuppressive and less immunogenic environment, they exhibit an additional function as the major source of Wnt5A in the TME. Significance: These findings demonstrate that myeloid cells provide a major source of Wnt5A to facilitate metastatic potential in melanoma cells and rely on Wnt5A for their immunosuppressive function.Other Versions
Funding Information
- HHS | NIH | National Cancer Institute (P30CA010815)
- HHS | NIH | National Cancer Institute (P30CA00697356)
- HHS | NIH | National Cancer Institute (R01CA174746)
- HHS | NIH | National Cancer Institute (R01CA207935)
- HHS | NIH | National Cancer Institute (P01 CA114046)
- HHS | NIH | National Cancer Institute (R01CA232256)
- HHS | NIH | National Cancer Institute (R00 CA208012)
- HHS | NIH | National Institute of Neurological Disorders and Stroke (R01 NS107342)
- HHS | NIH | National Institute of Neurological Disorders and Stroke (R01 NS114478)
This publication has 51 references indexed in Scilit:
- In vivo suppressive function of myeloid‐derived suppressor cells is limited to the inflammatory siteEuropean Journal of Immunology, 2011
- Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in CancerCancer Research, 2010
- STATs in cancer inflammation and immunity: a leading role for STAT3Nature Reviews Cancer, 2009
- Hear the Wnt Ror: how melanoma cells adjust to changes in WntPigment Cell & Melanoma Research, 2009
- Arginase I–Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated GranulocytesCancer Research, 2009
- Wnt5A Regulates Expression of Tumor-Associated Antigens in Melanoma via Changes in Signal Transducers and Activators of Transcription 3 PhosphorylationCancer Research, 2008
- Gene expression profiling during differentiation of human monocytes to macrophages or dendritic cellsJournal of Leukocyte Biology, 2007
- The Wnt5A/Protein Kinase C Pathway Mediates Motility in Melanoma Cells via the Inhibition of Metastasis Suppressors and Initiation of an Epithelial to Mesenchymal TransitionOnline Journal of Public Health Informatics, 2007
- The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulationBlood, 2006
- Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 The Journal of Experimental Medicine, 2003